세계의 심혈관용 디지털 솔루션 시장 (2023-2030) : 서비스 종류별 (비침습 검사, CVD 헬스 인포매틱스), 컴포넌트별, 전개별, 최종 용도별, 지역별

■ 영문 제목 : Cardiovascular Digital Solutions Market Size, Share & Trends Analysis Report By Service Type (Unobtrusive Testing, CVD Health Informatics), By Component, By Deployment, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Research 회사가 출판한 조사자료로, 코드는 GRV23MR063 입니다.■ 상품코드 : GRV23MR063
■ 조사/발행회사 : Grand View Research
■ 발행일 : 2023년 2월
■ 페이지수 : 90
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (납기:3일)
■ 조사대상 지역 : 세계
■ 산업 분야 : 의료
■ 판매가격 / 옵션 (부가세 10% 별도)
Single User (1인 열람용)USD5,950 ⇒환산₩8,032,500견적의뢰/주문/질문
Multi User (5인 열람용)USD6,950 ⇒환산₩9,382,500견적의뢰/주문/질문
Global/corporate License (기업 열람용)USD8,950 ⇒환산₩12,082,500견적의뢰/구입/질문
가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
Grand View Research사의 본 조사 보고서는 글로벌 심혈관용 디지털 솔루션 시장 규모가 2023년부터 2030년 사이에 CAGR 4.8% 증가하여, 2030년에는 1,486억 달러에 이를 것으로 예측하고 있습니다. 본 조사 자료는 글로벌 심혈관용 디지털 솔루션 시장을 조사대상으로 하여, 조사 범위 및 목적, 개요, 시장 변동/동향/범위, 컴포넌트별 (기기, 소프트웨어) 분석, 전개별 (클라우드, 온프레미스) 분석, 최종 용도별 (병원 및 진료소, 외래 진료 센터, 기타) 분석, 지역별 (북미, 유럽, 아시아 태평양, 중남미, 중동 및 아프리카) 분석, 경쟁 분석 등의 내용을 게재하고 있습니다. 또한 본 리포트는 Irythm Technologies, Inc., Apple Inc., General Electric Company, Uber Diagnostics, Alivcor, Inc., Verily Life Sciences Llc,, Heartflow, Inc., Bardy Diagnostics, Inc. ., Bio Telemetry, Inc., Koninkelijke Philips N.V., Evicore Healthcare 등의 기업 정보가 포함되어 있습니다.
・조사 범위 및 목적
・개요
・시장 변동/동향/범위
・글로벌 심혈관용 디지털 솔루션 시장 규모 : 컴포넌트별
- 기기의 시장 규모
- 소프트웨어의 시장 규모
・글로벌 심혈관용 디지털 솔루션 시장 규모 : 전개별
- 클라우드의 시장 규모
- 온프레미스의 시장 규모
・글로벌 심혈관용 디지털 솔루션 시장 규모 : 최종 용도별
- 병원 및 진료소에서 사용되는 심혈관용 디지털 솔루션의 시장 규모
- 외래 진료 센터에서 사용되는 심혈관용 디지털 솔루션의 시장 규모
- 기타 최종 용도에서사용되는 심혈관용 디지털 솔루션의 시장 규모
・글로벌 심혈관용 디지털 솔루션 시장 규모 : 지역별
- 북미의 심혈관용 디지털 솔루션 시장 규모
- 유럽의 심혈관용 디지털 솔루션 시장 규모
- 아시아 태평양의 심심혈관용 디지털 솔루션 시장 규모
- 중남미의 심혈관용 디지털 솔루션 시장 규모
- 중동과 아프리카의 심혈관용 디지털 솔루션 시장 규모
・경쟁 분석
■ 보고서 개요

Cardiovascular Digital Solutions Market Growth & Trends

The global cardiovascular digital solutions market size is expected to reach USD 148.6 billion by 2030 to expand at a CAGR of 4.8% from 2023 to 2030 based on a new report by Grand View Research, Inc. The increasing prevalence of cardiovascular diseases globally, continuously growing elderly population, rise in the awareness regarding the cardiac diseases and treatments among the population are some of the factors driving the growth of the market.

Digital solutions in cardiology are available in various forms such as monitoring devices, mobile phone applications, wearable technology, software, sensors, etc. These devices are efficient in monitoring, dealing with, and regulating chronic heart conditions. Digital therapeutics have been able to enhance treatment effectiveness while reducing the economic burden on patients and healthcare providers in a short period of time.

The COVID-19 pandemic has had a profound impact on the global economy and almost all aspects of personal lives. Procedure-based patient care has been largely suspended, owing to the need to expand the capacity of hospitals & health care systems and the aim to reduce the risks of infection for the patients and physicians. Similarly, diagnostic follow-ups and evaluations have either been postponed or rethought in approach. Cardiovascular management has therefore provided unique clinical concerns during the COVID-19 pandemic.

Cardiovascular Digital Solutions Market Report Highlights

• Based on service type, the unobtrusive segment accounted for the largest market share of 39.8% in 2022 as it is secure, care-setting-agnostic, and can efficiently manage large datasets. The CVD health informatics segment is expected to witness the fastest growth with a CAGR of 5.2% over the forecast period as it focuses on the collection, processing, transmission, retrieval, storage, interpretation, and usage of data from the cardiovascular system for the early detection and diagnosis cardiovascular diseases.

• Based on components, the devices segment dominated the market with a revenue share of 74.3% in 2022 owing to the increased prevalence of cardiovascular diseases and the increasing elderly population.

• Based on deployment, the cloud-based segment accounted for the largest revenue share of 67.7% in 2022 and is expected to continue its dominance over the forecast period as they offer more return on investment in the long run.

• Based on the end user, the hospitals & clinics segment dominated the market with a revenue share of 50.2% and is likely to grow at the fastest growth rate from 2023 to 2030. Efficient cardiac management can help hospitals and clinics to automate patient communication, increase their operational efficiency, and provide consistent and transparent cardiovascular treatment paths for patients.

• North America accounted for the largest revenue share of 40.2% in 2022 owing to the favorable reimbursement structure and the availability of telemedicine services. The Asia Pacific market is anticipated to witness rapid growth over the forecast period with a CAGR of 6.9%. The increase in the elderly population and increased development in the healthcare infrastructure driving the market expansion in the region.

■ 보고서 목차

Table of Contents

Chapter 1 Report Scope And Objectives
1.1 Market Segmentation & Scope
1.2 Regional Scope
1.2.1 Estimates And Forecast Timeline
1.3 Objectives
1.3.1 Objective – 1
1.3.2 Objective – 2
1.3.3 Objective – 3
Chapter 2 Methodology
2.1 Research Methodology
2.2 Information Procurement
2.2.1 Purchased Database
2.2.2 Gvr’s Internal Database
2.2.3 Secondary Sources
2.2.4 Primary Research
2.3 Information Or Data Analysis
2.3.1 Data Analysis Models
2.4 Market Formulation & Validation
2.5 Model Details
2.5.1 Commodity Flow Analysis (Model 1)
2.5.2 Volume Price Analysis (Model 2)
2.6 List Of Secondary Sources
Chapter 3 Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.2.1 Service Type
3.2.2 Components
3.2.3 Deployment
3.2.4 End-Use
3.2.5 Region
3.3 Competitive Insights
3.4 Cardiovascular Digital Solutions Market Outlook, 2022
Chapter 4 Market Variables, Trends & Scope
4.1 Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Cardiovascular Digital Solutions Market Dynamics
4.2.1 Market Driver Analysis
4.2.2 Market Restraint Analysis
4.3 Cardiovascular Digital Solutions Market: Business Environment Analysis Tools
4.3.1 Porter’s Five Forces Analysis
4.3.1.1 Threat Of New Entrants
4.3.1.2 Bargaining Power Of Suppliers
4.3.1.3 Bargaining Power Of Buyers
4.3.1.4 Competitive Rivalry
4.3.1.5 Threat Of Substitutes
4.3.2 Pestel Analysis
4.3.2.1 Political & Legal
4.3.2.2 Economic & Social
4.3.2.3 Technological
4.4 Penetration & Growth Prospect Mapping
4.5 Technology Trend Analysis
4.6 Regulatory Framework
4.7 Impact Of Covid-19 On Cardiovascular Digital Solutions Market
Chapter 5 Cardiovascular Digital Solutions Market: Service Type Analysis
5.1 Cardiovascular Digital Solutions Service Type Market Share Analysis, 2022 & 2030
5.2 Cardiovascular Digital Solutions, Deployment, Market: Segment Dashboard
5.3 Market Size & Forecasts And Trend Analyses, 2017 To 2030 For Service Type Segment
5.3.1 Unobtrusive Testing
5.3.1.1 Unobtrusive Testing Market, 2017 – 2030 (USD Million)
5.3.2 Cvd Health Informatics
5.3.2.1 Cvd Health Informatics Market, 2017 – 2030 (USD Million)
5.3.3 Cardiac Rehab Programs
5.3.3.1 Cardiac Rehab Programs Market, 2017 – 2030 (USD Million)
5.3.4 Others
5.3.4.1 Others Market, 2017 – 2030 (USD Million)
Chapter 6 Cardiovascular Digital Solutions Market: Components Analysis
6.1 Cardiovascular Digital Solutions Components Market Share Analysis, 2022 & 2030
6.2 Cardiovascular Digital Solutions Components Market: Segment Dashboard
6.3 Market Size & Forecasts And Trend Analyses, 2017 To 2030 For Components Segment
6.3.1 Devices
6.3.1.1 Devices Market, 2017 – 2030 (USD Million)
6.3.2 Software
6.3.2.1 Software Market, 2017 – 2030 (USD Million)
Chapter 7 Cardiovascular Digital Solutions Market: Deployment Analysis
7.1 Cardiovascular Digital Solutions Deployment Market Share Analysis, 2022 & 2030
7.2 Cardiovascular Digital Solutions Deployment Market: Segment Dashboard
7.3 Market Size & Forecasts And Trend Analyses, 2017 To 2030 For Components Segment
7.3.1 Cloud-Based
7.3.1.1 Cloud-Based Market 2017 – 2030 (USD Million)
7.3.2 On-Premise
7.3.2.1 On-Premise Market, 2017 – 2030 (USD Million)
Chapter 8 Cardiovascular Digital Solutions Market: End-Use Analysis
8.1 Cardiovascular Digital Solutions End-Use Market Share Analysis, 2021 & 2030
8.2 Cardiovascular Digital Solutions End-Use Market: Segment Dashboard
8.3 Market Size & Forecasts And Trend Analyses, 2017 To 2030 For The End-Use Segment
8.3.1 Hospitals & Clinics
8.3.1.1 Hospitals & Clinics Market, 2017 – 2030 (USD Million)
8.3.2 Ambulatory Care Centers
8.3.2.1 Ambulatory Care Centers Market, 2017 – 2030 (USD Million)
8.3.3 Others
8.3.3.1 Others Market, 2017 – 2030 (USD Million)
Chapter 9 Cardiovascular Digital Solutions Market: Regional Analysis
9.1 Cardiovascular Digital Solutions Regional Market Share Analysis, 2022 & 2030
9.2 Regional Market Snapshot
9.3 North America
9.3.1 North America Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.3.2 U.S.
9.3.2.1 U.S. Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.3.3 Canada
9.3.3.1 Canada Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.4 Europe
9.4.1 Europe Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.4.2 U.K.
9.4.2.1 U.K. Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.4.3 Germany
9.4.3.1 Germany Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.4.4 France
9.4.4.1 France Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.4.5 Italy
9.4.5.1 Italy Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.4.6 Spain
9.4.6.1 Spain Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.4.7. Russia
9.4.7.1 Russia Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.5 Asia Pacific
9.5.1 Asia Pacific Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.5.2 Japan
9.5.2.1 Japan Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.5.3 China
9.5.3.1 China Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.5.4 India
9.5.4.1 India Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.5.5 Australia
9.5.5.1 Australia Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.5.6 South Korea
9.5.6.1 South Korea Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.5.7 Singapore
9.5.7.1 Singapore Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.5.8 Thailand
9.5.8.1 Thailand Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.5.9 Malaysia
9.5.9.1 Malaysia Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.6 Latin America
9.6.1 Latin America Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.6.2 Brazil
9.6.2.1 Brazil Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.6.3 Mexico
9.6.3.1 Mexico Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.6.4 Colombia
9.6.4.1 Colombia Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.6.5 Argentina
9.6.5.1 Argentina Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.7 Middle East And Africa (Mea)
9.7.1 Mea Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.7.2 South Africa
9.7.2.1 South Africa Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.7.3 Saudi Arabia
9.7.3.1 Saudi Arabia Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.7.4 Uae
9.7.4.1 Uae Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.7.5 Kuwait
9.7.5.1 Kuwait Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
9.7.6 Israel
9.7.6.1 Israel Cardiovascular Digital Solutions Market, 2017 – 2030 (USD Million)
Chapter 10 Competitive Analysis
10.1 Recent Developments & Impact Analysis, By Key Market Participants
10.2 Company Profiles
10.3 Irythm Technologies, Inc.
10.3.1 Company Overview
10.3.2 Financial Performance
10.3.3 Product Benchmarking
10.3.4 Strategic Initiatives
10.4 Apple Inc.
10.4.1 Company Overview
10.4.2 Financial Performance
10.4.3 Product Benchmarking
10.4.4 Strategic Initiatives
10.5 General Electric Company
10.5.1 Company Overview
10.5.2 Financial Performance
10.5.3 Product Benchmarking
10.5.4 Strategic Initiatives
10.6 Uber Diagnostics
10.6.1 Company Overview
10.6.2 Financial Performance
10.6.3 Product Benchmarking
10.6.4 Strategic Initiatives
10.7 Alivcor, Inc.
10.7.1 Company Overview
10.7.2 Financial Performance
10.7.3 Product Benchmarking
10.7.4 Strategic Initiatives
10.8 Verily Life Sciences Llc,
10.8.1 Company Overview
10.8.2 Financial Performance
10.8.3 Product Benchmarking
10.8.4 Strategic Initiatives
10.9 Heartflow, Inc.
10.9.1 Company Overview
10.9.2 Financial Performance
10.9.3 Product Benchmarking
10.9.4 Strategic Initiatives
10.10 Bardy Diagnostics, Inc.
10.10.1 Company Overview
10.10.2 Financial Performance
10.10.3 Product Benchmarking
10.10.4 Strategic Initiatives
10.11 Bio Telemetry, Inc.
10.11.1 Company Overview
10.11.2 Financial Performance
10.11.3 Product Benchmarking
10.11.4 Strategic Initiatives
10.12 Koninkelijke Philips N.V.
10.12.1 Company Overview
10.12.2 Financial Performance
10.12.3 Product Benchmarking
10.12.4 Strategic Initiatives
10.13 Evicore Healthcare
10.13.1 Company Overview
10.13.2 Financial Performance
10.13.3 Product Benchmarking
10.13.4 Strategic Initiatives

보고서 이미지

※본 조사보고서 [세계의 심혈관용 디지털 솔루션 시장 (2023-2030) : 서비스 종류별 (비침습 검사, CVD 헬스 인포매틱스), 컴포넌트별, 전개별, 최종 용도별, 지역별] (코드 : GRV23MR063) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 심혈관용 디지털 솔루션 시장 (2023-2030) : 서비스 종류별 (비침습 검사, CVD 헬스 인포매틱스), 컴포넌트별, 전개별, 최종 용도별, 지역별] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!